How Digital Therapeutics Will Evolve in 2022 and Beyond

MHEALTHINTELLIGENCE, 04/02/2022

Partagé par : 

Beesens TEAM

How Digital Therapeutics Will Evolve in 2022 and Beyond

"The digital therapeutics arena has been steadily gaining ground, backed by growing clinical evidence, and leaders in the space believe that it will become a new standard of care.

As healthcare delivery has gone virtual, so have the clinical treatments themselves, resulting in a new category of medical interventions: digital therapeutics.

Digital therapeutics are evidence-based, clinically evaluated software and devices that can be used to treat an array of diseases and disorders, including pain, diabetes, anxiety, post-traumatic stress disorder, and asthma.

This new category of medicine has been growing over the past decade, steadily adding research and real-world evidence to support its use.

As digital therapeutics become validated and get incorporated into clinical care, another question arises: how will this category evolve alongside the pandemic in 2022 and beyond?

Growing clinical validation for digital therapeutics

For companies offering digital therapeutics, much of the past decade has been focused on developing their offerings and then testing to ensure they are clinically valid.

"Five years ago, digital therapeutics were still being tested and validated," said Eddie Martucci, co-founder and CEO of prescription digital medicine company Akili Interactive, in an email. "People had questions about the efficacy of DTx [digital therapeutics], and for many, digital therapeutics felt like science fiction. We've pushed hard for clinical validation in this industry, and in the last five years we've seen a significant amount of clinical validation for DTx, including compelling real-world data showing how these new approaches can help improve patients' lives."..." Lire la suite